Topics
October 2016 | business Of Retinainnovations In Retina
Visual Function Biomarkers Needed for Dry AMD
Early detection may allow treatment, and possibly reversal. Part 2 of a two-part series.
Aron Shapiro
March 2016 | business Of Retinainnovations In Retina
Ocular Gene Therapy Trials Advance
Results of the first phase 3 trial were announced.
August 6, 2026
Tarsus Pharmaceuticals to Acquire Alkeus Pharmaceuticals
August 5, 2026
Vantage Biosciences Completes Enrollment in Phase 2 SeeClear Trial of Oral NPDR Therapy
August 4, 2026
University of Iowa Research Underpins First-in-Human UK Study of Gene Therapy Targeting Rare IRD
Swedish Study Finds Small Absolute Risk of NAION Among GLP-1 Receptor Agonist Users
July/August 2026 Insert
Editorially independent supported by Abbvie and Regenxbio
July/August 2026 Supplement
Editorially Independent Content, Supported With Advertising From Astellas and ZEISS
July 2026 Supplement
Free Print Subscription
Email Newsletter
Conference Calendar
_1784132761.jpg?auto=compress,format&w=70)
